US4698341A
(en)
|
1983-07-30 |
1987-10-06 |
Godecke Aktiengesellschaft |
Use of 1,6-naphthyridinone derivatives in treating pulmonary thrombosis
|
JPS62209062A
(ja)
|
1986-03-10 |
1987-09-14 |
Yamanouchi Pharmaceut Co Ltd |
2−ピリジルメチルチオ−または2−ピリジルメチルスルフイニル−置換縮合環化合物
|
DE3804990A1
(de)
|
1988-02-18 |
1989-08-31 |
Basf Ag |
Herbizid wirksame, heterocyclisch substituierte sulfonamide
|
CA2053148A1
(en)
|
1990-10-16 |
1992-04-17 |
Karnail Atwal |
Dihydropyrimidine derivatives
|
US5326776A
(en)
|
1992-03-02 |
1994-07-05 |
Abbott Laboratories |
Angiotensin II receptor antagonists
|
WO1993017682A1
(en)
|
1992-03-04 |
1993-09-16 |
Abbott Laboratories |
Angiotensin ii receptor antagonists
|
JPH0789957A
(ja)
|
1993-09-22 |
1995-04-04 |
Nissan Chem Ind Ltd |
ビフェニルメチルアミン誘導体
|
TW263498B
(es)
|
1993-11-10 |
1995-11-21 |
Takeda Pharm Industry Co Ltd |
|
DE4344452A1
(de)
|
1993-12-24 |
1995-06-29 |
Hoechst Ag |
Aza-4-iminochinoline, Verfahren zu ihrer Herstellung und ihre Verwendung
|
ID16283A
(id)
|
1996-03-20 |
1997-09-18 |
Astra Pharma Prod |
Senyawa yang berguna dibidang farmasi
|
JP3531169B2
(ja)
|
1996-06-11 |
2004-05-24 |
三菱ウェルファーマ株式会社 |
縮合ヘテロ環化合物およびその医薬用途
|
CN1233254A
(zh)
|
1996-10-16 |
1999-10-27 |
Icn药品公司 |
嘌呤l-核苷、其类似物及其用途
|
US6177464B1
(en)
|
1997-03-14 |
2001-01-23 |
Sepracor, Inc. |
Ring opening metathesis of alkenes
|
US6339099B1
(en)
|
1997-06-20 |
2002-01-15 |
Dupont Pharmaceuticals Company |
Guanidine mimics as factor Xa inhibitors
|
ES2310039T3
(es)
|
1998-05-26 |
2008-12-16 |
Warner-Lambert Company Llc |
Pirimidinas biciclicas y 3,4-dihidropirimidinas biciclicas como inhibidores de la proliferacion celular.
|
AU4429799A
(en)
|
1998-06-12 |
1999-12-30 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
JP2000123973A
(ja)
|
1998-10-09 |
2000-04-28 |
Canon Inc |
有機発光素子
|
DE19900545A1
(de)
|
1999-01-11 |
2000-07-13 |
Basf Ag |
Verwendung von Pyrimidinderivaten zur Prophylaxe und Therapie der zerebralen Ischämie
|
AU4589800A
(en)
|
1999-05-05 |
2000-11-21 |
Darwin Discovery Limited |
9-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,9-dihydropurin-6-one derivatives as pde7inhibitors
|
WO2000067754A1
(en)
|
1999-05-12 |
2000-11-16 |
Nitromed, Inc. |
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
|
EA200200424A1
(ru)
|
1999-09-30 |
2002-12-26 |
Ньюроджен Корпорейшн |
Некоторые гетероциклы, замещенные алкилендиамином
|
TWI271406B
(en)
|
1999-12-13 |
2007-01-21 |
Eisai Co Ltd |
Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
|
ATE305302T1
(de)
|
1999-12-28 |
2005-10-15 |
Eisai Co Ltd |
Heterozyklische verbindungen mit sulfonamid- gruppen
|
DE60110749T2
(de)
|
2000-02-09 |
2006-02-02 |
Novartis Ag |
Pyridinderivative als angiogenese- und/oder vegf-rezeptor-tyrosinkinase-inhibitoren
|
AU2001245856A1
(en)
|
2000-03-23 |
2001-10-03 |
Merck & Co., Inc. |
Thrombin inhibitors
|
CA2413330A1
(en)
|
2000-06-28 |
2002-01-03 |
Smithkline Beecham P.L.C. |
Wet milling process
|
CN1509140A
(zh)
|
2001-05-15 |
2004-06-30 |
�Ű˾ |
作为杀菌剂的吡啶基稠合二环酰胺
|
US20030139431A1
(en)
|
2001-09-24 |
2003-07-24 |
Kawakami Joel K. |
Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors
|
JP2003107641A
(ja)
|
2001-09-27 |
2003-04-09 |
Fuji Photo Film Co Ltd |
ハロゲン化銀感光材料
|
EP1471910A2
(en)
|
2002-01-17 |
2004-11-03 |
Neurogen Corporation |
Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
|
EP1481678A4
(en)
|
2002-03-05 |
2009-12-30 |
Eisai R&D Man Co Ltd |
ANTITUMORAL AGENT CONTAINING A SULFONAMIDE-CONTAINING HETEROCYCLIC COMPOUND AND AN ANGIOGENESIS INHIBITOR
|
JP2006504665A
(ja)
|
2002-08-13 |
2006-02-09 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
マトリックスメタロプロテイナーゼ阻害剤としてのアザイソキノリン誘導体
|
JP3908248B2
(ja)
|
2002-08-13 |
2007-04-25 |
塩野義製薬株式会社 |
Hivインテグラーゼ阻害活性を有するヘテロ環化合物
|
AU2003282726B2
(en)
|
2002-10-03 |
2010-10-07 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
WO2004031161A1
(en)
|
2002-10-04 |
2004-04-15 |
Prana Biotechnology Limited |
Neurologically-active compounds
|
JP4552651B2
(ja)
|
2002-10-30 |
2010-09-29 |
味の素株式会社 |
複素環化合物
|
BR0317168A
(pt)
|
2002-12-13 |
2005-11-01 |
Neurogen Corp |
Composto ou uma forma farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos de reduzir condutância de cálcio de um receptor de capsaicina celular, e de inibir ligação de ligante vanilóide a um receptor de capsaicina, métodos de tratar uma condição responsiva à modulação de receptor de capsaicina, dor, coceira, tosse ou soluços, incontinência urinária, de promover perda de peso em paciente, e de determinar a presença ou ausência de receptor de capsaicina em uma amostra, preparação farmacêutica embalada, e, uso de um composto
|
JP2004196702A
(ja)
|
2002-12-18 |
2004-07-15 |
Yamanouchi Pharmaceut Co Ltd |
新規なアミド誘導体又はその塩
|
JP2006519846A
(ja)
|
2003-03-10 |
2006-08-31 |
シェーリング コーポレイション |
複素環式キナーゼインヒビター:使用および合成の方法
|
EP1613322A4
(en)
|
2003-04-11 |
2008-08-13 |
Taigen Biotechnology Co Ltd |
AMINOQUINOLINE COMPOUNDS
|
AU2004253967B2
(en)
|
2003-07-03 |
2010-02-18 |
Cytovia, Inc. |
4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
|
AU2004257267B2
(en)
|
2003-07-14 |
2009-12-03 |
Arena Pharmaceuticals,Inc |
Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
|
KR20060097105A
(ko)
|
2003-07-22 |
2006-09-13 |
얀센 파마슈티카 엔.브이. |
C-fms 키나아제 저해제로서의 퀴놀리논 유도체
|
WO2005028478A1
(en)
|
2003-09-19 |
2005-03-31 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
EP2065383A1
(en)
|
2003-11-19 |
2009-06-03 |
Signal Pharmaceuticals, Inc. |
Indazole compounds and methods of use thereof as protein kinase inhibitors
|
JP2007513154A
(ja)
|
2003-12-08 |
2007-05-24 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物及び方法
|
CA2553670A1
(en)
|
2004-01-29 |
2005-08-11 |
Elixir Pharmaceuticals, Inc. |
Anti-viral therapeutics
|
US20050182060A1
(en)
|
2004-02-13 |
2005-08-18 |
Kelly Michael G. |
2-Substituted and 4-substituted aryl nitrone compounds
|
GB0403635D0
(en)
|
2004-02-18 |
2004-03-24 |
Devgen Nv |
Pyridinocarboxamides with improved activity as kinase inhibitors
|
JPWO2005080377A1
(ja)
|
2004-02-20 |
2007-10-25 |
キリンホールディングス株式会社 |
TGFβ阻害活性を有する化合物およびそれを含んでなる医薬組成物
|
AU2005244736B2
(en)
|
2004-05-07 |
2012-06-28 |
Exelixis Patent Company Llc |
Raf modulators and methods of use
|
US20060074102A1
(en)
|
2004-05-14 |
2006-04-06 |
Kevin Cusack |
Kinase inhibitors as therapeutic agents
|
WO2005121138A2
(en)
|
2004-06-03 |
2005-12-22 |
Rigel Pharmaceuticals, Inc. |
Heterotricyclic compounds for use as hcv inhibitors
|
GB0412467D0
(en)
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
DE102004041163A1
(de)
|
2004-08-25 |
2006-03-02 |
Morphochem Aktiengesellschaft für kombinatorische Chemie |
Neue Verbindungen mit antibakterieller Aktivität
|
GB0420970D0
(en)
|
2004-09-21 |
2004-10-20 |
Smithkline Beecham Corp |
Novel triazoloquinoline compounds
|
US20070054916A1
(en)
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
US8093273B2
(en)
|
2004-10-20 |
2012-01-10 |
Resverlogix Corp. |
Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
|
FR2877013A1
(fr)
|
2004-10-27 |
2006-04-28 |
Assist Publ Hopitaux De Paris |
Indentification d'une mutation de jak2 impliquee dans la polyglobulie de vaquez
|
WO2006065842A2
(en)
|
2004-12-13 |
2006-06-22 |
Synta Pharmaceuticals Corp. |
5,6,7,8-tetrahydroquinolines and related compounds and uses thereof
|
CA2592900A1
(en)
|
2005-01-03 |
2006-07-13 |
Myriad Genetics Inc. |
Nitrogen containing bicyclic compounds and therapeutical use thereof
|
MX2007008287A
(es)
|
2005-01-07 |
2007-09-07 |
Pfizer Prod Inc |
Compuestos de quinolina heteroaromaticos.
|
RU2007140733A
(ru)
|
2005-04-06 |
2009-05-20 |
Айрм Ллк (Bm) |
Диариламинсодержащие соединения и композиции, и их применение в качестве модуляторов ядерных рецепторов стероидного гормона
|
AU2006244074B2
(en)
|
2005-05-09 |
2012-12-13 |
Hydra Biosciences, Inc. |
Compounds for modulating TRPV3 function
|
WO2007002781A2
(en)
|
2005-06-28 |
2007-01-04 |
Bausch & Lomb Incorporated |
Preparations comprising arylazine substituted with a carbonylic moiety to increase the activity of gelatinase a in ocular cells
|
EP2251341A1
(en)
|
2005-07-14 |
2010-11-17 |
Astellas Pharma Inc. |
Heterocyclic Janus kinase 3 inhibitors
|
JP5071374B2
(ja)
*
|
2005-07-14 |
2012-11-14 |
アステラス製薬株式会社 |
ヘテロ環ヤヌスキナーゼ3阻害剤
|
KR101431279B1
(ko)
|
2005-07-29 |
2014-08-20 |
리스버로직스 코퍼레이션 |
복합 질환의 예방 및 치료용 약학적 조성물 및 삽입가능한의료 장치에 의한 이의 전달
|
EP1917245A1
(de)
|
2005-08-21 |
2008-05-07 |
Abbott GmbH & Co. KG |
Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
|
CN101253159B
(zh)
|
2005-09-01 |
2011-12-07 |
弗·哈夫曼-拉罗切有限公司 |
作为p2x3和p2x2/3调节剂的二氨基嘧啶类化合物
|
MX2008004024A
(es)
|
2005-09-23 |
2009-02-27 |
Schering Corp |
Antagonistas de receptor de glutamato metabotropico-1 tetraciclicos fusionados como agentes terapeuticos.
|
WO2007047653A2
(en)
|
2005-10-17 |
2007-04-26 |
Sloan-Kettering Institute For Cancer Research |
Synthetic hla binding peptide analogues of mutant v617f jak2 enzyme and uses therefor
|
WO2007051062A2
(en)
|
2005-10-28 |
2007-05-03 |
Chemocentryx, Inc. |
Substituted dihydropyridines and methods of use
|
US7989461B2
(en)
|
2005-12-23 |
2011-08-02 |
Amgen Inc. |
Substituted quinazolinamine compounds for the treatment of cancer
|
WO2007082131A1
(en)
|
2006-01-09 |
2007-07-19 |
Bristol-Myers Squibb Company |
Process for the preparation of hydroxy substituted heterocycles
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2007110868A2
(en)
|
2006-03-28 |
2007-10-04 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
WO2007113565A1
(en)
|
2006-04-06 |
2007-10-11 |
Astrazeneca Ab |
Naphthyridine derivatives as anti-cancer agents
|
WO2007125405A2
(en)
|
2006-05-01 |
2007-11-08 |
Pfizer Products Inc. |
Substituted 2-amino-fused heterocyclic compounds
|
WO2007133637A2
(en)
|
2006-05-10 |
2007-11-22 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
JP2009537520A
(ja)
|
2006-05-15 |
2009-10-29 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Fgf受容体キナーゼ阻害剤のための組成物および方法
|
JO3235B1
(ar)
|
2006-05-26 |
2018-03-08 |
Astex Therapeutics Ltd |
مركبات بيررولوبيريميدين و استعمالاتها
|
EP2044026B1
(en)
|
2006-06-22 |
2014-03-26 |
Prana Biotechnology Limited |
Method of treatment of glioma brain tumour
|
KR20090023645A
(ko)
|
2006-06-28 |
2009-03-05 |
사노피-아벤티스 |
신규한 cxcr2 억제제
|
KR20090031544A
(ko)
|
2006-06-29 |
2009-03-26 |
쉐링 코포레이션 |
치환된 비사이클릭 및 트리사이클릭 트롬빈 수용체 길항제
|
JP5185930B2
(ja)
|
2006-07-07 |
2013-04-17 |
ブリストル−マイヤーズ スクイブ カンパニー |
ピロロトリアジンキナーゼ阻害剤
|
GB0614052D0
(en)
|
2006-07-14 |
2006-08-23 |
Amura Therapeutics Ltd |
Compounds
|
ES2344760T3
(es)
|
2006-07-20 |
2010-09-06 |
Amgen Inc. |
Compuestos de piridona sustituidos y metodo de uso.
|
US20080021013A1
(en)
|
2006-07-21 |
2008-01-24 |
Cephalon, Inc. |
JAK inhibitors for treatment of myeloproliferative disorders
|
US7531539B2
(en)
|
2006-08-09 |
2009-05-12 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
AU2007285976B2
(en)
|
2006-08-14 |
2011-08-18 |
Xencor, Inc |
Optimized antibodies that target CD19
|
WO2008024977A2
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Isoquinoline, quinazoline and phthalazine derivatives
|
US8642598B2
(en)
|
2006-10-21 |
2014-02-04 |
Abbvie Inc. |
Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
|
KR100789731B1
(ko)
|
2006-11-15 |
2008-01-03 |
전남대학교산학협력단 |
파이로시퀀싱을 이용한 jak2 v617f 돌연변이의 정량적검출방법, 시발체 및 키트
|
JP2010510317A
(ja)
|
2006-11-20 |
2010-04-02 |
ブリストル−マイヤーズ スクイブ カンパニー |
ジペプチジルペプチダーゼivの阻害剤としての7,8−ジヒドロ−1,6−ナフチリジン−5(6h)−オンおよび関連二環式化合物、および方法
|
CA2673038C
(en)
|
2006-12-22 |
2015-12-15 |
Incyte Corporation |
Substituted tricyclic heteroaryl compounds as janus kinase inhibitors
|
US20100105661A1
(en)
|
2007-01-12 |
2010-04-29 |
Astellas Pharma Inc. |
Condensed pyridine compound
|
ES2454966T3
(es)
|
2007-02-01 |
2014-04-14 |
Resverlogix Corp. |
Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
|
EP2134346B1
(en)
|
2007-03-13 |
2011-09-21 |
Merck Sharp & Dohme Corp. |
Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1
|
EP1972627A1
(en)
|
2007-03-19 |
2008-09-24 |
Technische Universität Carolo-Wilhelmina zu Braunschweig |
Amino-napthyridine derivatives
|
CA2682504C
(en)
|
2007-04-05 |
2012-10-30 |
Amgen Inc. |
Aurora kinase modulators and method of use
|
US8039505B2
(en)
|
2007-04-11 |
2011-10-18 |
University Of Utah Research Foundation |
Compounds for modulating T-cells
|
WO2008135524A2
(en)
|
2007-05-02 |
2008-11-13 |
Boehringer Ingelheim International Gmbh |
Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments
|
KR20090130347A
(ko)
|
2007-05-09 |
2009-12-22 |
화이자 인코포레이티드 |
치환된 헤테로사이클릭 유도체 및 조성물 및 항균제로서의 이의 약학적 용도
|
SG185285A1
(en)
|
2007-06-03 |
2012-11-29 |
Univ Vanderbilt |
Benzamide mglur5 positive allosteric modulators and methods of making and using same
|
US9321730B2
(en)
|
2007-08-21 |
2016-04-26 |
The Hong Kong Polytechnic University |
Method of making and administering quinoline derivatives as anti-cancer agents
|
US8227639B2
(en)
|
2007-09-26 |
2012-07-24 |
Cardioxyl Pharmaceuticals |
N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
|
UA101493C2
(ru)
|
2008-03-11 |
2013-04-10 |
Инсайт Корпорейшн |
Производные азетидина и циклобутана как ингибиторы jak
|
WO2009146034A2
(en)
|
2008-03-31 |
2009-12-03 |
Takeda Pharmaceutical Company Limited |
Mapk/erk kinase inhibitors and methods of use thereof
|
WO2010002472A1
(en)
|
2008-07-02 |
2010-01-07 |
Ambit Biosciences Corporation |
Jak kinase modulating compounds and methods of use thereof
|
WO2010006130A2
(en)
|
2008-07-09 |
2010-01-14 |
Envivo Pharmaceuticals, Inc. |
Pde-10 inhibitors
|
JP5281647B2
(ja)
|
2008-09-08 |
2013-09-04 |
日本曹達株式会社 |
含窒素ヘテロ環化合物およびその塩並びに農園芸用殺菌剤
|
EP2344476B1
(en)
|
2008-09-23 |
2015-04-29 |
Rigel Pharmaceuticals, Inc. |
Tricyclic carbamate jak inhibitors
|
JP5592890B2
(ja)
|
2008-10-08 |
2014-09-17 |
ブリストル−マイヤーズ スクイブ カンパニー |
ピロロトリアジンキナーゼ阻害剤
|
KR20110102468A
(ko)
|
2008-12-16 |
2011-09-16 |
서트리스 파마슈티컬즈, 인코포레이티드 |
시르투인 조절제로서의 프탈라지논 및 관련 유사체
|
AR074760A1
(es)
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
MX2011006333A
(es)
|
2008-12-23 |
2011-06-27 |
Abbott Lab |
Compuestos antivirales.
|
MX2011007130A
(es)
|
2008-12-29 |
2012-01-20 |
Southern Res Inst |
Compuestos antivirales, tratamiento y dosis.
|
BRPI1011477A2
(pt)
|
2009-03-02 |
2016-03-22 |
Sirtris Pharmaceuticals Inc |
quinolinas 8-substituidas e analogos relacionados como moduladores de sirtuina
|
NZ595747A
(en)
|
2009-03-18 |
2015-06-26 |
Resverlogix Corp |
Novel quinazolinones and related compounds for use as anti-inflammatory agents
|
JP2012520887A
(ja)
|
2009-03-18 |
2012-09-10 |
シェーリング コーポレイション |
ジアシルグリセロールアシルトランスフェラーゼの阻害剤としての二環式化合物
|
JP2012521988A
(ja)
|
2009-03-23 |
2012-09-20 |
シーメンス メディカル ソリューションズ ユーエスエー インコーポレイテッド |
神経学的障害を検知するためのイメージング剤
|
US8691187B2
(en)
|
2009-03-23 |
2014-04-08 |
Eli Lilly And Company |
Imaging agents for detecting neurological disorders
|
KR20190091564A
(ko)
|
2009-04-22 |
2019-08-06 |
리스버로직스 코퍼레이션 |
신규한 소염제
|
GB0907551D0
(en)
|
2009-05-01 |
2009-06-10 |
Univ Dundee |
Treatment or prophylaxis of proliferative conditions
|
CA2760791C
(en)
|
2009-05-07 |
2017-06-20 |
Intellikine, Inc. |
Heterocyclic compounds and uses thereof
|
WO2010141062A1
(en)
|
2009-06-04 |
2010-12-09 |
Ludwig Institute For Cancer Research Ltd. |
Inhibitors of constitutively active janus kinases and uses thereof
|
FI2440546T3
(fi)
|
2009-06-12 |
2023-03-30 |
Abivax |
Ennenaikaisen vanhenemisen ja erityisesti progerian hoitamiseen hyödyllisiä yhdisteitä
|
US10253020B2
(en)
|
2009-06-12 |
2019-04-09 |
Abivax |
Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging
|
WO2011004276A1
(en)
|
2009-07-06 |
2011-01-13 |
Pfizer Limited |
Hepatitis c virus inhibitors
|
IN2012DN01961A
(es)
|
2009-08-17 |
2015-08-21 |
Intellikine Llc |
|
ES2505270T3
(es)
|
2009-09-03 |
2014-10-09 |
Bristol-Myers Squibb Company |
Inhibidores de JAK2 y su uso para el tratamiento de enfermedades mieloproliferativas y cáncer
|
KR101097315B1
(ko)
|
2009-10-12 |
2011-12-23 |
삼성모바일디스플레이주식회사 |
유기 발광 소자
|
IN2012DN03312A
(es)
|
2009-10-22 |
2015-10-23 |
Fibrotech Therapeutics Pty Ltd |
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
ES2658290T3
(es)
|
2009-10-29 |
2018-03-09 |
Genosco |
Inhibidores de cinasa
|
CA2781010A1
(en)
|
2009-12-01 |
2011-06-09 |
Abbott Laboratories |
Novel tricyclic compounds
|
EP2521724B1
(en)
|
2009-12-11 |
2016-11-23 |
Nono Inc. |
Agents and methods for treating ischemic and other diseases
|
AR079529A1
(es)
|
2009-12-18 |
2012-02-01 |
Incyte Corp |
Derivados arilo y heteroarilo sustituidos y fundidos como inhibidores de la pi3k
|
WO2011078143A1
(ja)
|
2009-12-22 |
2011-06-30 |
塩野義製薬株式会社 |
ピリミジン誘導体およびそれらを含有する医薬組成物
|
EP2518064A1
(en)
|
2009-12-25 |
2012-10-31 |
Mochida Pharmaceutical Co., Ltd. |
Novel aryl urea derivative
|
TW201129565A
(en)
|
2010-01-12 |
2011-09-01 |
Hoffmann La Roche |
Tricyclic heterocyclic compounds, compositions and methods of use thereof
|
WO2011097717A1
(en)
|
2010-02-15 |
2011-08-18 |
University Of Victoria Innovation And Development Corporation |
Synthesis of bicyclic compounds and method for their use as therapeutic agents
|
US9403769B2
(en)
|
2010-02-22 |
2016-08-02 |
Advanced Cancer Therapeutics, Llc |
Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics
|
WO2011112687A2
(en)
|
2010-03-10 |
2011-09-15 |
Kalypsys, Inc. |
Heterocyclic inhibitors of histamine receptors for the treatment of disease
|
CN102933081B
(zh)
|
2010-04-02 |
2016-04-13 |
赛诺米克斯公司 |
甜味改良剂
|
WO2011137428A1
(en)
|
2010-04-30 |
2011-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of treating hiv infection: inhibition of dna dependent protein kinase
|
AU2011255218B2
(en)
|
2010-05-21 |
2015-03-12 |
Infinity Pharmaceuticals, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
US8299117B2
(en)
|
2010-06-16 |
2012-10-30 |
Metabolex Inc. |
GPR120 receptor agonists and uses thereof
|
RS54750B1
(sr)
|
2010-10-26 |
2016-10-31 |
Mars Inc |
Borati kao inhibitori arginaze
|
JP2013541591A
(ja)
|
2010-11-04 |
2013-11-14 |
アムジエン・インコーポレーテツド |
複素環化合物およびそれらの使用
|
RU2597609C2
(ru)
|
2010-11-18 |
2016-09-10 |
Касина Лайла Иннова Фармасьютикалз Прайвит Лимитед |
Замещенные 4-(селенофен-2(или 3)-иламино)пиримидиновые соединения и способы их применения
|
WO2012078902A2
(en)
|
2010-12-08 |
2012-06-14 |
Proteostasis Therapeutics, Inc. |
Proteostasis regulators
|
CN102603628B
(zh)
|
2010-12-22 |
2016-08-17 |
香港理工大学 |
作为抗癌试剂的喹啉衍生物
|
WO2012085176A1
(en)
|
2010-12-23 |
2012-06-28 |
F. Hoffmann-La Roche Ag |
Tricyclic pyrazinone compounds, compositions and methods of use thereof as janus kinase inhibitors
|
US9090592B2
(en)
|
2010-12-30 |
2015-07-28 |
AbbVie Deutschland GmbH & Co. KG |
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
|
WO2012097479A1
(en)
|
2011-01-21 |
2012-07-26 |
Abbott Laboratories |
Bicyclic inhibitors of anaphastic lymphoma kinase
|
US20120214842A1
(en)
|
2011-02-18 |
2012-08-23 |
Exonhit Therapeutics Sa |
Methods for treating diseases of the retina
|
EP2678016B1
(en)
|
2011-02-23 |
2016-08-10 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
EP2688890B1
(en)
*
|
2011-03-22 |
2017-08-30 |
Advinus Therapeutics Limited |
Substituted fused tricyclic compounds, compositions and medicinal applications thereof
|
US9433219B2
(en)
|
2011-04-20 |
2016-09-06 |
The Regents Of The University Of California |
Fungi antagonistic to xylella fastidiosa
|
CN102838601A
(zh)
|
2011-06-24 |
2012-12-26 |
山东亨利医药科技有限责任公司 |
选择性磷酰肌醇3-激酶δ抑制剂
|
CN102838600A
(zh)
|
2011-06-24 |
2012-12-26 |
山东亨利医药科技有限责任公司 |
苯基喹唑啉类PI3Kδ抑制剂
|
WO2013007765A1
(en)
|
2011-07-13 |
2013-01-17 |
F. Hoffmann-La Roche Ag |
Fused tricyclic compounds for use as inhibitors of janus kinases
|
WO2013033268A2
(en)
|
2011-08-29 |
2013-03-07 |
Coferon, Inc. |
Bivalent bromodomain ligands, and methods of using same
|
AR091790A1
(es)
|
2011-08-29 |
2015-03-04 |
Infinity Pharmaceuticals Inc |
Derivados de isoquinolin-1-ona y sus usos
|
WO2013033093A1
(en)
|
2011-08-29 |
2013-03-07 |
Biocryst Pharmaceuticals, Inc. |
Heterocyclic compounds as janus kinase inhibitors
|
WO2013033981A1
(zh)
|
2011-09-06 |
2013-03-14 |
江苏先声药物研究有限公司 |
一类2,7-萘啶衍生物及其制备方法和应用
|
US20140227321A1
(en)
|
2011-09-30 |
2014-08-14 |
Kineta, Inc. |
Anti-viral compounds
|
WO2013062987A1
(en)
|
2011-10-24 |
2013-05-02 |
New York University |
Methods for identifying janus kinase (jak) modulators for therapeutics
|
WO2013067036A1
(en)
|
2011-10-31 |
2013-05-10 |
Rutgers, The State University Of New Jersey |
Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators
|
EP2788332A1
(en)
|
2011-12-07 |
2014-10-15 |
Amgen, Inc. |
Bicyclic aryl and heteroaryl sodium channel inhibitors
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
WO2013158928A2
(en)
|
2012-04-18 |
2013-10-24 |
Elcelyx Therapeutics, Inc. |
Chemosensory receptor ligand-based therapies
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
JP6198814B2
(ja)
|
2012-05-08 |
2017-09-20 |
メルク・アンド・コンパニー |
18f標識された葉酸/葉酸代謝拮抗物質同族体
|
US10155987B2
(en)
|
2012-06-12 |
2018-12-18 |
Dana-Farber Cancer Institute, Inc. |
Methods of predicting resistance to JAK inhibitor therapy
|
US9260436B2
(en)
|
2012-06-22 |
2016-02-16 |
Sumitomo Chemical Company, Limited |
Fused heterocyclic compound
|
BR112015001613B1
(pt)
|
2012-07-27 |
2021-02-23 |
Biogen Ma Inc |
compostos que são agentes de modulação de s1p e/ou agentes de modulação de atx, seus usos e composição farmacêutica
|
EP3424936B1
(de)
|
2012-08-07 |
2021-04-07 |
Merck Patent GmbH |
Metallkomplexe
|
EP2900639B1
(en)
|
2012-09-27 |
2017-08-16 |
Portola Pharmaceuticals, Inc. |
Bicyclic dihydropyridone kinase inhibitors
|
FR2996129B1
(fr)
|
2012-09-28 |
2014-12-19 |
Oreal |
Procede de coloration capillaire mettant en oeuvre au moins un derive d'heterocycle azote, un sel de manganese ou de zinc, du peroxyde d'hydrogene et du (bi)carbonate
|
CA2890699A1
(en)
|
2012-11-07 |
2014-05-15 |
Novartis Ag |
Combination therapy
|
WO2014080290A2
(en)
|
2012-11-21 |
2014-05-30 |
Rvx Therapeutics Inc. |
Cyclic amines as bromodomain inhibitors
|
WO2014087165A1
(en)
|
2012-12-06 |
2014-06-12 |
University Of Bath |
Tankyrase inhibitors
|
JP6434425B2
(ja)
|
2013-01-29 |
2018-12-05 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
S1p調節剤
|
KR102081281B1
(ko)
|
2013-02-08 |
2020-05-28 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
KR102147424B1
(ko)
|
2013-03-08 |
2020-08-25 |
에스에프씨 주식회사 |
유기발광 화합물 및 이를 포함하는 유기전계발광소자
|
US9333213B2
(en)
|
2013-03-15 |
2016-05-10 |
Duke University |
Prochelators as broad-spectrum antimicrobial agents and methods of use
|
CA2914310A1
(en)
|
2013-06-18 |
2014-12-24 |
Novartis Ag |
Pharmaceutical combinations
|
WO2014204263A1
(en)
|
2013-06-20 |
2014-12-24 |
The Asan Foundation |
Substituted pyridinone compounds as mek inhibitors
|
KR101682020B1
(ko)
|
2013-06-28 |
2016-12-02 |
제일모직 주식회사 |
화합물, 이를 포함하는 유기 광전자 소자 및 표시장치
|
ES2898385T3
(es)
|
2013-07-05 |
2022-03-07 |
Abivax |
Compuestos bicíclicos útiles para el tratamiento de enfermedades causadas por retrovirus
|
AU2014290108A1
(en)
|
2013-07-16 |
2016-02-04 |
Kineta, Inc. |
Anti-viral compounds, pharmaceutical compositions, and methods of use thereof
|
KR20160043118A
(ko)
|
2013-08-21 |
2016-04-20 |
리스버로직스 코퍼레이션 |
가속화된 경화반 퇴행을 위한 조성물 및 치료방법
|
AR097631A1
(es)
|
2013-09-16 |
2016-04-06 |
Bayer Pharma AG |
Trifluorometilpirimidinonas sustituidas con heterociclos y sus usos
|
JP6498667B2
(ja)
|
2013-10-04 |
2019-04-10 |
メルク パテント ゲーエムベーハー |
電子素子のための材料としてのトリアリールアミン置換ベンゾ[h]キノリン誘導体
|
JP6483697B2
(ja)
|
2013-12-09 |
2019-03-13 |
ユーシービー バイオファルマ エスピーアールエル |
Tnf活性のモジュレーターとしての縮合二環式ヘテロ芳香族誘導体
|
CN104725249B
(zh)
|
2013-12-20 |
2019-02-12 |
广东东阳光药业有限公司 |
苄胺类衍生物及其在药物上的应用
|
CN104860931A
(zh)
|
2014-02-21 |
2015-08-26 |
常州寅盛药业有限公司 |
丙肝病毒抑制剂及其制药用途
|
EP3124482B1
(en)
|
2014-03-24 |
2019-09-11 |
Guangdong Zhongsheng Pharmaceutical Co., Ltd |
Quinoline derivatives as smo inhibitors
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
US9902702B2
(en)
|
2014-07-15 |
2018-02-27 |
Bristol-Myers Squibb Company |
Spirocycloheptanes as inhibitors of rock
|
US20160016951A1
(en)
|
2014-07-17 |
2016-01-21 |
Merck Patent Gmbh |
Novel naphthyridines and isoquinolines and their use as cdk8/19 inhibitors
|
CN105461714B
(zh)
|
2014-09-29 |
2017-11-28 |
山东轩竹医药科技有限公司 |
并环类pi3k抑制剂
|
KR102308118B1
(ko)
|
2014-10-22 |
2021-10-01 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
CN104311426A
(zh)
|
2014-10-27 |
2015-01-28 |
厦门大学 |
芳香硝基乙烯化合物的新用途
|
CN105732591B
(zh)
|
2014-12-31 |
2019-10-25 |
广东东阳光药业有限公司 |
取代的哌嗪化合物及其使用方法和用途
|
WO2016116900A1
(en)
|
2015-01-23 |
2016-07-28 |
Gvk Biosciences Private Limited |
Inhibitors of trka kinase
|
US10227343B2
(en)
|
2015-01-30 |
2019-03-12 |
Vanderbilt University |
Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
|
AU2016217874A1
(en)
|
2015-02-11 |
2017-08-10 |
Basilea Pharmaceutica International AG |
Substituted mono- and polyazanaphthalene derivatives and their use
|
EP3059591A1
(en)
|
2015-02-23 |
2016-08-24 |
Abivax |
Methods for screening compounds for treating or preventing a viral infection or a virus-related condition
|
US20180237797A1
(en)
|
2015-03-30 |
2018-08-23 |
Jeffrey Thomas Loh |
Methods for in vitro production of platelets and compositions and uses thereof
|
CN105481765A
(zh)
|
2015-04-15 |
2016-04-13 |
江苏艾凡生物医药有限公司 |
一类用于治疗心力衰竭的酰腙类衍生物
|
KR101904300B1
(ko)
|
2015-04-15 |
2018-10-04 |
삼성에스디아이 주식회사 |
유기 광전자 소자용 화합물, 이를 포함하는 유기 광전자 소자 및 표시장치
|
WO2016190847A1
(en)
|
2015-05-26 |
2016-12-01 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
US10588907B2
(en)
|
2015-06-04 |
2020-03-17 |
Kura Oncology, Inc. |
Methods and compositions for inhibiting the interaction of menin with MLL proteins
|
US9902696B2
(en)
|
2015-06-18 |
2018-02-27 |
Cephalon, Inc. |
1,4-substituted piperidine derivatives
|
KR20180015160A
(ko)
|
2015-06-22 |
2018-02-12 |
오노 야꾸힝 고교 가부시키가이샤 |
Brk 저해 화합물
|
WO2017004134A1
(en)
|
2015-06-29 |
2017-01-05 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
KR102192691B1
(ko)
|
2015-06-30 |
2020-12-17 |
(주)피엔에이치테크 |
유기발광 화합물 및 이를 포함하는 유기전계발광소자
|
EP3317277B1
(en)
|
2015-07-01 |
2021-01-20 |
Crinetics Pharmaceuticals, Inc. |
Somatostatin modulators and uses thereof
|
JP2018523679A
(ja)
|
2015-08-17 |
2018-08-23 |
ルピン・リミテッド |
Parp阻害剤としてのヘテロアリール誘導体
|
CA2999523A1
(en)
|
2015-10-02 |
2017-04-06 |
Dana-Farber Cancer Institute, Inc. |
Combination therapy of bromodomain inhibitors and checkpoint blockade
|
MA52119A
(fr)
|
2015-10-19 |
2018-08-29 |
Ncyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
WO2017072039A1
(de)
|
2015-10-26 |
2017-05-04 |
Bayer Cropscience Aktiengesellschaft |
Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
|
EA201891049A1
(ru)
|
2015-10-29 |
2018-10-31 |
Эффектор Терапьютикс, Инк. |
Изоиндолиновые, азаизоиндолиновые, дигидроинденоновые и дигидроазаинденоновые ингибиторы mnk1 и mnk2
|
AR106515A1
(es)
|
2015-10-29 |
2018-01-24 |
Bayer Cropscience Ag |
Sililfenoxiheterociclos trisustituidos y análogos
|
MA43131B1
(fr)
|
2015-10-30 |
2020-07-29 |
Calithera Biosciences Inc |
Compositions et procédés d'inhibition de l'activité de l'arginase
|
SG11201804152RA
(en)
|
2015-11-19 |
2018-06-28 |
Incyte Corp |
Heterocyclic compounds as immunomodulators
|
WO2017090002A2
(en)
|
2015-11-27 |
2017-06-01 |
Gvk Biosciences Private Limited |
Inhibitors of pi3 kinases
|
TW201726623A
(zh)
|
2015-12-17 |
2017-08-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
US10646465B2
(en)
|
2015-12-17 |
2020-05-12 |
Biokine Therapeutics Ltd. |
Small molecules against cancer
|
EP4292650A3
(en)
|
2015-12-22 |
2024-02-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2017184462A1
(en)
|
2016-04-18 |
2017-10-26 |
Celgene Quanticel Research, Inc. |
Therapeutic compounds
|
AR108396A1
(es)
|
2016-05-06 |
2018-08-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
EP3464286B1
(en)
|
2016-05-24 |
2021-08-18 |
Genentech, Inc. |
Pyrazolopyridine derivatives for the treatment of cancer
|
WO2017205464A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
KR102685249B1
(ko)
|
2016-06-20 |
2024-07-17 |
인사이트 코포레이션 |
면역조절제로서의 복소환식 화합물
|
CA3025806C
(en)
|
2016-06-23 |
2023-04-04 |
Dana-Farber Cancer Institute, Inc. |
Degradation of bromodomain-containing protein 9 (brd9) by conjugation of brd9 inhibitors with e3 ligase ligand and methods of use
|
US10730858B2
(en)
|
2016-07-07 |
2020-08-04 |
Bristol-Myers Squibb Company |
Lactam, cyclic urea and carbamate, and triazolone derivatives as potent and selective rock inhibitors
|
MA45669A
(fr)
|
2016-07-14 |
2019-05-22 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
GB201615282D0
(en)
|
2016-09-08 |
2016-10-26 |
Univ Bath |
Tankyrase inhibitors
|
TW201825465A
(zh)
|
2016-09-23 |
2018-07-16 |
美商基利科學股份有限公司 |
磷脂醯肌醇3-激酶抑制劑
|
CN110312711A
(zh)
|
2016-10-07 |
2019-10-08 |
亚瑞克西斯制药公司 |
作为ras抑制剂的杂环化合物及其使用方法
|
SG11201903892UA
(en)
|
2016-11-02 |
2019-05-30 |
Janssen Pharmaceutica Nv |
[1,2,4]triazolo[1,5-a]pyrimidine derivatives as pde2 inhibitors
|
JOP20190144A1
(ar)
|
2016-12-16 |
2019-06-16 |
Janssen Pharmaceutica Nv |
إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
|
AU2017382405B2
(en)
|
2016-12-22 |
2021-12-16 |
Calithera Biosciences, Inc. |
Compositions and methods for inhibiting arginase activity
|
WO2018140600A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
Fused hetero-hetero bicyclic compounds and methods of use thereof
|
US11274093B2
(en)
|
2017-01-26 |
2022-03-15 |
Araxes Pharma Llc |
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
|
WO2018144478A1
(en)
|
2017-01-31 |
2018-08-09 |
The Regents Of The University Of California |
Organisms antagonistic to xylella fastidiosa
|
US11066420B2
(en)
|
2017-05-01 |
2021-07-20 |
Sanford Burnham Prebys Medical Discovery Institute |
Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof
|
WO2018204765A1
(en)
|
2017-05-05 |
2018-11-08 |
Pairnomix, Llc |
Methods of treating epilepsy and kcnq2 related conditions
|
US20210246227A1
(en)
|
2017-05-31 |
2021-08-12 |
Elstar Therapeutics, Inc. |
Multispecific molecules that bind to myeloproliferative leukemia (mpl) protein and uses thereof
|
WO2018231745A1
(en)
|
2017-06-14 |
2018-12-20 |
Trevena, Inc. |
Compounds for modulating s1p1 activity and methods of using the same
|
WO2018237370A1
(en)
|
2017-06-23 |
2018-12-27 |
Accro Bioscience Inc. |
HETEROARYL COMPOUNDS AS INHIBITORS OF THE NECROSIS, COMPOSITION AND METHOD OF USE THEREOF
|
WO2019060860A1
(en)
|
2017-09-25 |
2019-03-28 |
Suzhou Yunxuan Yiyao Keji Youxian Gongsi |
HETEROARYL COMPOUNDS AS INHIBITORS OF CXCR4, COMPOSITION AND METHOD OF USE THEREOF
|
MA50629A
(fr)
|
2017-10-02 |
2021-03-31 |
Merck Sharp & Dohme |
Composés monobactames de chromane pour le traitement d'infections bactériennes
|
CN109575022B
(zh)
|
2017-12-25 |
2021-09-21 |
成都海博锐药业有限公司 |
一种化合物及其用途
|
CN109608504B
(zh)
|
2017-12-28 |
2022-04-05 |
广州华睿光电材料有限公司 |
有机金属配合物、聚合物、混合物、组合物和有机电子器件
|
CN109988109B
(zh)
|
2017-12-29 |
2020-12-29 |
广东东阳光药业有限公司 |
抑制ssao/vap-1的胺类化合物及其用途
|
EP3735242A4
(en)
|
2018-01-03 |
2021-09-01 |
Merck Sharp & Dohme Corp. |
METALLO-BETA-LACTAMASE INHIBITORS AND THEIR METHODS OF USE
|
US11384069B2
(en)
|
2018-01-16 |
2022-07-12 |
Shenzhen Targetrx, Inc. |
Diphenylaminopyrimidine compound for inhibiting kinase activity
|
US12012394B2
(en)
|
2018-02-19 |
2024-06-18 |
Washington University |
Alpha-synuclein ligands
|
WO2019177975A1
(en)
|
2018-03-12 |
2019-09-19 |
The Board Of Trustees Of The University Of Illinois |
Antibiotics effective for gram-negative pathogens
|
WO2019201283A1
(en)
|
2018-04-20 |
2019-10-24 |
Xrad Therapeutics, Inc. |
Dual atm and dna-pk inhibitors for use in anti-tumor therapy
|
WO2019214546A1
(zh)
|
2018-05-11 |
2019-11-14 |
四川科伦博泰生物医药股份有限公司 |
稠环化合物、其制备方法及用途
|
CN111484480B
(zh)
|
2019-01-29 |
2023-08-11 |
上海翰森生物医药科技有限公司 |
一种多环类衍生物抑制剂、其制备方法和应用
|
WO2021018012A1
(zh)
|
2019-07-26 |
2021-02-04 |
珠海宇繁生物科技有限责任公司 |
一种irak4激酶抑制剂及其制备方法
|
US11753413B2
(en)
|
2020-06-19 |
2023-09-12 |
Incyte Corporation |
Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
|
US11691971B2
(en)
|
2020-06-19 |
2023-07-04 |
Incyte Corporation |
Naphthyridinone compounds as JAK2 V617F inhibitors
|
US11767323B2
(en)
|
2020-07-02 |
2023-09-26 |
Incyte Corporation |
Tricyclic pyridone compounds as JAK2 V617F inhibitors
|
WO2022046989A1
(en)
|
2020-08-27 |
2022-03-03 |
Incyte Corporation |
Tricyclic urea compounds as jak2 v617f inhibitors
|
WO2022140231A1
(en)
|
2020-12-21 |
2022-06-30 |
Incyte Corporation |
Deazaguaine compounds as jak2 v617f inhibitors
|
US11958861B2
(en)
|
2021-02-25 |
2024-04-16 |
Incyte Corporation |
Spirocyclic lactams as JAK2 V617F inhibitors
|